Expanding the Limits: Transapical Transcatheter Aortic Valve for Severe Aortic Regurgitation [1]
In this manuscript, the authors describe their experience with the treatment of 8 high risk patients with pure, severe aortic valve regurgitation, using the self-expandable Acurate TA prosthesis through a transapical approach. All procedures were carried out successfully with no 30-day mortality or stroke. None of the patients had more that grade I residual aortic regurgitation and none of them required permanent pacemaker implantation.